ELL2 and prostate cancer: Downregulated expression of transcription regulators in high-risk UM could help identify potential tumor-suppressor genes, however only the downregulation of ELL2 is associated with prostate cancer and multiple myeloma based on our current knowledge [39,40,41,42].